Project Grant H79SM083530

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

The National Science Foundation awarded a $195,381 Project Grant to Washington State University under the Biological Sciences program (CFDA 47.074) for the period of February 1, 2021 through January 31, 2024. The grant aims to fund the RAPID project "Curtailing Nosocomial Amplification of COVID-19," which seeks to develop epidemiological models to better understand and mitigate the transmission of COVID-19 in healthcare settings. As part of the grant, Research Triangle Institute will...

The Healthtrends.ai LLC federal Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provided $256,000 to develop a coronavirus API focused on COVID-19 from May 2021 through June 2022. The grant supported the awardee's SBIR Phase I project to create an application programming interface delivering COVID-19 data and insights. As the NSF's TIP program seeks technologies and solutions addressing national challenges, this award aimed to...

Federal Project Grant Award Summary Advanced Brain Monitoring, Inc. received a $325,672 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 16, 2025, with completion targeted for May 31, 2027. The company will develop and validate a novel mobile electroencephalography (EEG) platform to objectively assess neurocognitive deficits associated with post-acute sequelae of...

Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston Children's Hospital $489,500 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop innovative human cellular models for studying tuberculosis (TB) infection and innate immune responses. The award, effective August 1, 2025, through July 31, 2027, funds the establishment of a physiological in vitro lung alveolar epithelial cell organoid model derived...

The National Science Foundation (NSF) awarded a $100,000 Project Grant under the Social, Behavioral, and Economic Sciences program (CFDA 47.075) to Trustees of Boston University. The grant will fund a 2-year research project to improve the estimation of epidemic quantities and assessment of intervention impacts for acute infectious diseases by incorporating realistic behavioral feedback into mechanistic models. The project involves recruiting individuals with acute respiratory infections...

Federal Project Grant Award Summary Brigham & Women's Hospital Inc., Department of Faulkner Pathology, received a $194,400 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 15, 2025, with completion scheduled for August 31, 2029. The grant supports research to define vaccine immunogenicity and adoptive transfer mechanisms in allogeneic hematopoietic stem cell...

The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...

This $131,988 Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, supports research targeting determinants of SARS-CoV-2 host interaction in airways. Funded through the Cardiovascular Diseases Research program, the grant aims to identify master regulator proteins that mechanistically regulate SARS-CoV-2 interactions in the airways. Using organotypic airway epithelial culture and systems biology tools at Columbia University, the...

Federal Project Grant Award Summary Brigham & Women's Hospital Inc. received a $484,752 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the use of chest radiography (CXR) in detecting early-stage tuberculosis (TB) in children and youth. The research initiative, which commenced on September 23, 2025, and concludes on August 31, 2027, leverages existing data from a...